Fig. 3
From: Gene mutation, clinical characteristics and pathology in resectable lung adenocarcinoma
Comparison of overall survival times between genetic mutations. A: EGFR mutation, B: ALK fusion, C: KRAS mutation, D: EGFR mutation subtypes, E: KRAS mutation subtypes